1. Home
  2. FRME vs HAE Comparison

FRME vs HAE Comparison

Compare FRME & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FRME

First Merchants Corporation

HOLD

Current Price

$41.21

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$79.84

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRME
HAE
Founded
1893
1971
Country
United States
United States
Employees
2086
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
FRME
HAE
Price
$41.21
$79.84
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$48.33
$84.13
AVG Volume (30 Days)
272.9K
933.4K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
3.62%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
$27.67
N/A
Revenue Next Year
$5.91
$5.23
P/E Ratio
$10.90
$38.44
Revenue Growth
N/A
N/A
52 Week Low
$34.66
$47.32
52 Week High
$43.22
$87.32

Technical Indicators

Market Signals
Indicator
FRME
HAE
Relative Strength Index (RSI) 59.25 83.08
Support Level $40.84 $78.87
Resistance Level $41.66 $86.72
Average True Range (ATR) 0.79 2.92
MACD 0.13 1.60
Stochastic Oscillator 88.93 97.01

Price Performance

Historical Comparison
FRME
HAE

About FRME First Merchants Corporation

First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment, which is community banking.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: